About ONCOSPHERIX INC
OncoSpherix is a mission-driven biotechnology company focused on developing first-in-class small molecule therapies to treat advanced cancers by targeting hypoxia-driven gene expression. The company was founded in 2018 and is led by CEO Dr. Margaret Offermann.
Development of first-in-class small molecules that disable adaptive responses in cancerDesign and characterization of new chemical entities that block hypoxia-driven gene expressionPreclinical testing of compounds in multiple cancer models including glioblastoma, uveal melanoma, lung adenocarcinoma, breast cancer, and pancreatic cancerCollaboration with other companies to develop combination therapies for advanced cancers
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ONCOSPHERIX INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.